A detailed history of Two Sigma Investments, LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 465,170 shares of PACB stock, worth $907,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
465,170
Previous 835,420 44.32%
Holding current value
$907,081
Previous $1.14 Million 30.94%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $444,300 - $803,442
-370,250 Reduced 44.32%
465,170 $790,000
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $879,550 - $2.36 Million
646,728 Added 342.74%
835,420 $1.14 Million
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $405,218 - $1.1 Million
115,119 Added 156.47%
188,692 $707,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $1.73 Million - $2.99 Million
-289,084 Reduced 79.71%
73,573 $721,000
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $3.31 Million - $5.6 Million
-402,115 Reduced 52.58%
362,657 $3.03 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $7.03 Million - $9.9 Million
704,972 Added 1178.88%
764,772 $10.2 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $339,066 - $669,760
59,800 New
59,800 $489,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $5.63 Million - $14.6 Million
1,399,307 Added 45.31%
4,487,462 $19.8 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $22.8 Million - $56.4 Million
2,699,194 Added 693.95%
3,088,155 $28.1 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $10.3 Million - $16 Million
-532,651 Reduced 57.8%
388,961 $7.96 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $14.7 Million - $20.7 Million
-591,117 Reduced 39.08%
921,612 $23.5 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $2.18 Million - $3.52 Million
97,846 Added 6.92%
1,512,729 $52.9 Million
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $37.3 Million - $72.4 Million
1,414,883 New
1,414,883 $47.1 Million
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $103,585 - $283,209
-28,694 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $76,039 - $115,636
28,694 New
28,694 $99,000
Q1 2018

May 15, 2018

SELL
$2.05 - $3.23 $287,610 - $453,162
-140,298 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.59 - $5.44 $363,371 - $763,221
140,298
140,298 $370,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.